Fast and smooth cross-border movement of vaccines, vaccine inputs and related supplies is essential for the world to achieve its vaccination targets without delay.
The WTO-IMF Vaccine Trade Tracker provides data on the trade and supply of COVID-19 vaccines by product, economy and arrangement type. The tracker builds on the work of the WTO Secretariat information notes on COVID-19 and world trade and the IMF Staff Discussion Note – A Proposal to End the COVID-19 Pandemic (Agarwal and Gopinath, 2021).
This Tracker shows the supply of vaccine doses from facilities where the final vaccines are made (where “fill and finish” is completed) to the economies where they are administered; cases where production facilities are located within destination economies are referred to as “domestic supply”. For vaccines that only require one dose (J&J and CanSino), volumes are doubled to make them comparable with two-shot vaccines. This should be considered when comparing these numbers to other sources.
Total supply to date: 14.4 billion doses
Domestic supply: 8.6 billion doses
Implicit trade (exports or imports): 5.7 billion doses
Exports are defined as the number of doses delivered across borders from producing economies to economies where vaccines are administered.
This Tracker defines a “producing economy” as a country or territory where final vaccines are made or where “fill and finish” is completed. This definition does not take into account exports of vaccine substances in bulk form shipped to “fill and finish” sites located in other countries or territories.
|Producing economy||Number of doses (million)||Share of world exports||Cumulative share||Exports as share of total supply|
|United States of America||859.1||15%||87.2%||58.4%|
|Korea, Republic of||235.8||4.1%||91.3%||91.1%|
|Note: as of 31 March 2022|
This Tracker identifies five different arrangements through which the vaccines can reach the destination economies (not including domestic supply). These arrangements are 1) contracted supply via COVAX; 2) donations via COVAX; 3) supply via bilateral deals; 4) direct donations; and 5) supply via AVAT (African Vaccine Acquisition Trust).